SUMMARY A national Venous Thromboembolism (VTE) Prevention Programme was
introduced in England in 2010, with limited subsequent study of its impact. Whilst the …

Hospital‐acquired venous thromboembolism (VTE) remains the number one safety issue in
hospitals and is estimated to cause more preventable deaths than the more publicized …

The article offers updated National Institute for Health and Care Excellence (NICE)
guidance, of 2018 on venous thromboembolism (VTE). Topics discussed include significant …

Hospital‐associated venous thromboembolism remains a major international cause of
avoidable mortality and morbidity. Although the publication of national guidelines does …

Venous thromboembolism (VTE) remains a leading cause of preventable morbidity and
mortality associated with hospitalization. Despite evidence that providing appropriate …

Venous thromboembolism is a serious healthcare problem affecting over 1 in 1000 adults
worldwide annually. 1 Epidemiological studies have shown that before the use of …

Background Hospital‐acquired venous thromboembolism (VTE) is a major cause of
morbidity and mortality. Aims To determine the proportion of patients with hospital‐acquired …

Health-care organizations need to develop a strategy to ensure that all hospitalized patients
receive appropriate thromboprophylaxis. This review describes an evidence-based model …

Introduction: Hospital-acquired venous thromboembolism (VTE) is a potentially fatal
complication of hospitalisation, with meta-analyses and guidelines supporting the use of …

Objective Since 2010, National Health Service hospitals in England have been incentivised
to risk assess for Venous Thromboembolism (VTE) in all adult patients admitted, using a …